NCT01091649View on ClinicalTrials.gov

Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy
Interventions
DRUG

ABT-450

Low dose ABT-450 / ritonavir see Arm Description for more information

DRUG

ritonavir

ritonavir see Arm Description for more information

DRUG

ABT-450

High dose ABT-450 / ritonavir See Arm Description for more information

Trial Locations (1)

60085

Site Reference ID/Investigator# 27781, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY